A novel 3D breast-cancer-on-chip platform for therapeutic evaluation of drug delivery systems

A novel 3D breast-cancer-on-chip platform was developed to monitor in real-time the dynamic transport of nanoparticles and to perform cytotoxicity assays on one platform, which enables accurate prediction of drug release behavior for better preclinical drug evaluation.218